Annual revenue:
$43.27M-$2.75M(-5.97%)Summary
- As of today (June 17, 2025), EYPT annual revenue is $43.27 million, with the most recent change of -$2.75 million (-5.97%) on December 31, 2024.
- During the last 3 years, EYPT annual revenue has risen by +$6.33 million (+17.15%).
- EYPT annual revenue is now -5.97% below its all-time high of $46.02 million, reached on December 31, 2023.
Performance
EYPT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$24.45M+$12.87M(+111.02%)Summary
- As of today (June 17, 2025), EYPT quarterly revenue is $24.45 million, with the most recent change of +$12.87 million (+111.02%) on March 31, 2025.
- Over the past year, EYPT quarterly revenue has increased by +$12.77 million (+109.29%).
- EYPT quarterly revenue is now -3.37% below its all-time high of $25.31 million, reached on September 30, 2014.
Performance
EYPT Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$56.04M+$12.77M(+29.51%)Summary
- As of today (June 17, 2025), EYPT TTM revenue is $56.04 million, with the most recent change of +$12.77 million (+29.51%) on March 31, 2025.
- Over the past year, EYPT TTM revenue has increased by +$6.02 million (+12.04%).
- EYPT TTM revenue is now at all-time high.
Performance
EYPT TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EYPT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.0% | +109.3% | +12.0% |
| 3 y3 years | +17.1% | +163.1% | +44.0% |
| 5 y5 years | +112.5% | +226.5% | +116.9% |
EYPT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.0% | +17.1% | at high | +218.3% | at high | +50.1% |
| 5 y | 5-year | -6.0% | +112.5% | at high | +493.2% | at high | +146.3% |
| alltime | all time | -6.0% | >+9999.0% | -3.4% | >+9999.0% | at high | >+9999.0% |
EYPT Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $24.45M(+111.0%) | $56.04M(+29.5%) |
| Dec 2024 | $43.27M(-6.0%) | $11.59M(+10.1%) | $43.27M(-5.3%) |
| Sep 2024 | - | $10.52M(+11.0%) | $45.71M(-9.3%) |
| Jun 2024 | - | $9.48M(-18.9%) | $50.39M(+0.7%) |
| Mar 2024 | - | $11.68M(-16.7%) | $50.02M(+8.7%) |
| Dec 2023 | $46.02M(+11.1%) | $14.03M(-7.7%) | $46.02M(+8.2%) |
| Sep 2023 | - | $15.20M(+67.0%) | $42.52M(+13.9%) |
| Jun 2023 | - | $9.11M(+18.5%) | $37.33M(-6.2%) |
| Mar 2023 | - | $7.68M(-27.1%) | $39.79M(-3.9%) |
| Dec 2022 | $41.40M(+12.1%) | $10.53M(+5.2%) | $41.40M(-2.4%) |
| Sep 2022 | - | $10.01M(-13.4%) | $42.41M(+2.3%) |
| Jun 2022 | - | $11.56M(+24.4%) | $41.46M(+6.6%) |
| Mar 2022 | - | $9.29M(-19.5%) | $38.91M(+5.3%) |
| Dec 2021 | $36.94M(+7.3%) | $11.54M(+27.4%) | $36.94M(+13.6%) |
| Sep 2021 | - | $9.06M(+0.5%) | $32.53M(-16.9%) |
| Jun 2021 | - | $9.01M(+23.1%) | $39.16M(+14.3%) |
| Mar 2021 | - | $7.32M(+2.7%) | $34.27M(-0.5%) |
| Dec 2020 | $34.44M(+69.1%) | $7.13M(-54.6%) | $34.44M(-4.2%) |
| Sep 2020 | - | $15.70M(+280.8%) | $35.94M(+58.0%) |
| Jun 2020 | - | $4.12M(-45.0%) | $22.75M(-12.0%) |
| Mar 2020 | - | $7.49M(-13.3%) | $25.84M(+26.9%) |
| Dec 2019 | $20.36M(+595.5%) | $8.63M(+244.1%) | $20.36M(+73.6%) |
| Sep 2019 | - | $2.51M(-65.2%) | $11.73M(+20.8%) |
| Jun 2019 | - | $7.21M(+258.3%) | $9.71M(+202.1%) |
| Mar 2019 | - | $2.01M(+314.0%) | $3.21M(+4.9%) |
| Dec 2018 | $2.93M(-1.1%) | - | - |
| Sep 2018 | - | $486.00K(-32.0%) | $3.06M(+3.4%) |
| Jun 2018 | $2.96M(-60.7%) | $715.00K(-23.0%) | $2.96M(+0.5%) |
| Mar 2018 | - | $928.00K(-0.5%) | $2.95M(+13.0%) |
| Dec 2017 | - | $933.00K(+142.3%) | $2.61M(-65.9%) |
| Sep 2017 | - | $385.00K(-45.1%) | $7.65M(+1.4%) |
| Jun 2017 | $7.54M(+365.4%) | $701.00K(+18.8%) | $7.54M(+5.6%) |
| Mar 2017 | - | $590.00K(-90.1%) | $7.14M(+3.9%) |
| Dec 2016 | - | $5.97M(+2055.6%) | $6.88M(+380.5%) |
| Sep 2016 | - | $277.00K(-8.9%) | $1.43M(-11.7%) |
| Jun 2016 | $1.62M(-93.9%) | $304.00K(-6.2%) | $1.62M(-6.1%) |
| Mar 2016 | - | $324.00K(-38.4%) | $1.73M(-0.2%) |
| Dec 2015 | - | $526.00K(+12.9%) | $1.73M(+0.3%) |
| Sep 2015 | - | $466.00K(+13.9%) | $1.72M(-93.5%) |
| Jun 2015 | $26.57M(+664.9%) | $409.00K(+24.7%) | $26.57M(+0.4%) |
| Mar 2015 | - | $328.00K(-37.0%) | $26.45M(-5.9%) |
| Dec 2014 | - | $521.00K(-97.9%) | $28.11M(-0.3%) |
| Sep 2014 | - | $25.31M(+8566.8%) | $28.18M(+711.5%) |
| Jun 2014 | $3.47M | $292.00K(-85.3%) | $3.47M(-5.4%) |
| Mar 2014 | - | $1.99M(+236.5%) | $3.67M(+67.4%) |
| Dec 2013 | - | $592.00K(-0.8%) | $2.19M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | $597.00K(+21.3%) | $2.19M(+2.1%) |
| Jun 2013 | $2.14M(-39.2%) | $492.00K(-4.1%) | $2.14M(-8.8%) |
| Mar 2013 | - | $513.00K(-12.3%) | $2.35M(-1.1%) |
| Dec 2012 | - | $585.00K(+5.8%) | $2.38M(-1.9%) |
| Sep 2012 | - | $553.00K(-20.9%) | $2.42M(-31.4%) |
| Jun 2012 | $3.53M(-29.0%) | $699.00K(+29.9%) | $3.53M(-46.1%) |
| Mar 2012 | - | $538.00K(-14.6%) | $6.54M(+2.8%) |
| Dec 2011 | - | $630.00K(-62.0%) | $6.36M(+3.5%) |
| Sep 2011 | - | $1.66M(-55.3%) | $6.15M(+23.8%) |
| Jun 2011 | $4.96M(-78.5%) | $3.71M(+931.9%) | $4.96M(-70.7%) |
| Mar 2011 | - | $360.00K(-13.0%) | $16.97M(-0.9%) |
| Dec 2010 | - | $414.00K(-13.0%) | $17.13M(-15.0%) |
| Sep 2010 | - | $476.00K(-97.0%) | $20.15M(-12.6%) |
| Jun 2010 | $23.05M(+89.5%) | $15.72M(+2952.8%) | $23.05M(+118.4%) |
| Mar 2010 | - | $515.00K(-85.0%) | $10.55M(-20.1%) |
| Dec 2009 | - | $3.43M(+1.5%) | $13.20M(+3.6%) |
| Sep 2009 | - | $3.38M(+5.0%) | $12.74M(+4.7%) |
| Jun 2009 | $12.16M(+249.9%) | $3.22M(+1.9%) | $12.16M(+4.5%) |
| Mar 2009 | - | $3.16M(+6.5%) | $11.64M(+29.1%) |
| Dec 2008 | - | $2.97M(+5.8%) | $9.02M(+46.0%) |
| Sep 2008 | - | $2.81M(+3.8%) | $6.18M(+77.8%) |
| Jun 2008 | $3.48M(+55.5%) | $2.70M(+398.7%) | $3.48M(+183.1%) |
| Mar 2008 | - | $542.00K(+323.4%) | $1.23M(+63.5%) |
| Dec 2007 | - | $128.00K(+24.3%) | $751.00K(-33.6%) |
| Sep 2007 | - | $103.00K(-77.4%) | $1.13M(-37.8%) |
| Jun 2007 | $2.23M(+52.6%) | $455.00K(+600.0%) | $1.82M(+2.6%) |
| Mar 2007 | - | $65.00K(-87.2%) | $1.77M(-13.9%) |
| Dec 2006 | - | $508.00K(-35.7%) | $2.06M(-7.3%) |
| Sep 2006 | - | $790.40K(+93.1%) | $2.22M(+23.0%) |
| Jun 2006 | $1.47M(+134.7%) | $409.30K(+16.3%) | $1.81M(+17.3%) |
| Mar 2006 | - | $351.90K(-47.5%) | $1.54M(+14.2%) |
| Dec 2005 | - | $670.70K(+78.8%) | $1.35M(+60.5%) |
| Sep 2005 | - | $375.10K(+161.9%) | $840.50K(+36.4%) |
| Jun 2005 | $624.30K(+135.4%) | $143.20K(-10.7%) | $616.10K(+18.6%) |
| Mar 2005 | - | $160.40K(-0.9%) | $519.50K(+20.3%) |
| Dec 2004 | - | $161.80K(+7.4%) | $432.00K(+26.3%) |
| Sep 2004 | - | $150.70K(+223.4%) | $342.00K(+33.5%) |
| Jun 2004 | $265.20K(+256.5%) | $46.60K(-36.1%) | $256.20K(+9.6%) |
| Mar 2004 | - | $72.90K(+1.5%) | $233.80K(+31.6%) |
| Dec 2003 | - | $71.80K(+10.6%) | $177.60K(+46.4%) |
| Sep 2003 | - | $64.90K(+168.2%) | $121.30K(+69.9%) |
| Jun 2003 | $74.40K(-85.6%) | $24.20K(+44.9%) | $71.40K(+51.3%) |
| Mar 2003 | - | $16.70K(+7.7%) | $47.20K(+54.8%) |
| Dec 2002 | - | $15.50K(+3.3%) | $30.50K(+103.3%) |
| Sep 2002 | - | $15.00K | $15.00K |
| Jun 2002 | $516.30K(+794.8%) | - | - |
| Jun 2001 | $57.70K | - | - |
FAQ
- What is EyePoint Pharmaceuticals annual revenue?
- What is the all time high annual revenue for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual revenue year-on-year change?
- What is EyePoint Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly revenue year-on-year change?
- What is EyePoint Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals TTM revenue year-on-year change?
What is EyePoint Pharmaceuticals annual revenue?
The current annual revenue of EYPT is $43.27M
What is the all time high annual revenue for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual revenue is $46.02M
What is EyePoint Pharmaceuticals annual revenue year-on-year change?
Over the past year, EYPT annual revenue has changed by -$2.75M (-5.97%)
What is EyePoint Pharmaceuticals quarterly revenue?
The current quarterly revenue of EYPT is $24.45M
What is the all time high quarterly revenue for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly revenue is $25.31M
What is EyePoint Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, EYPT quarterly revenue has changed by +$12.77M (+109.29%)
What is EyePoint Pharmaceuticals TTM revenue?
The current TTM revenue of EYPT is $56.04M
What is the all time high TTM revenue for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high TTM revenue is $56.04M
What is EyePoint Pharmaceuticals TTM revenue year-on-year change?
Over the past year, EYPT TTM revenue has changed by +$6.02M (+12.04%)